abbvie glp-1 receptor agonist weight management diabetes treatments Evolution of GLP‐1 Agonists for Treatment GLP-1 Receptor Agonists for the
Description
241 In -cells of patients with T2DM, the ability of GLP-1(936) to inhibit glucagon secretion is lost
This is because tirzepatide works a bit differently from other similar medicines
Both are released in response to eating nutrientsspecifically amino acids, glucose, dietary fiber, and fatty acids in food
It also places strong emphasis on the quality of the diet.
